Prion Diseases:  Fatal and greatly feared.  : A review of current knowledge, two and a half centuries after the 1st description of scrapie. by Kaldestad, Sarah Kristine
 1 
Prion Diseases:  Fatal and greatly feared. 
A review of current knowledge, two and a half centuries after the 1st 
description of scrapie. 
 
 
 
Sarah Kristine Kaldestad, H-05 
01.10.10 
 
 
 
 
Faculty of Medicine 
UNIVERSITY OF OSLO 
Advisor:  Jan Mæhlen, M.D., Ph.D., Professor of Pathology, Ullevaal 
University Hospital 
 2 
ABSTRACT 
Prion diseases (or transmissible spongiform encephalopathies) are rare, infectious 
neurodegenerative disorders caused by the accumulation of aberrant prion proteins in the brain.  
TSEs can affect both animals and humans and can be transmitted with varying degrees of 
efficiency between species.  Prion disease can be sporadic, genetic, or acquired.  Testing in 
humans is not feasible, yet, alarmingly, vCJD has been shown to transmit through blood 
transfusions.  Other patients have been iatrogenically infected from surgical instruments that were 
contaminated with prions.  Prions are extremely difficult to inactivate and standard disinfection 
methods for surgical equipment are inadequate.  There are at present time no effective treatments 
for TSEs in humans or in animals.  The incubation time is generally long, but death usually 
occurs within months after the onset of clinical disease.  The aim of this paper is to present an 
overview of the prion diseases, including medical, historical, legal, and economical perspectives.   
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I. Introduction 
Medical students at the University of Oslo are required to write a thesis paper on a topic 
of their own choosing.  I have chosen prion diseases, a topic that has interested me since the first 
reported case of mad cow disease in the United Kingdom in 1996.   
 I am a native of Seattle, Washington.  I returned for a visit to Seattle in December 2003 at 
the same time that the U.S. had its first case of mad cow disease.  A dairy cow from a farm in 
Mabton, Washington was reported to have had mad cow disease, and the meat had been 
consumed by people in Washington state.   
The Holstein cow had been imported from Alberta, Canada in 2001.  The animal was 
slaughtered on Dec. 9, 2003.  It had apparently become paralyzed while giving birth and was thus 
considered a “downer cow”, meaning that it was unable to walk at the time of slaughter1.   
Because it was a downer cow, screening tests for bovine spongiform encephalopathy (BSE or 
mad cow disease) were taken and shipped to the United States Department of Agriculture’s 
laboratory in Iowa
1
.  The most high risk parts of the animal; the brain, spinal cord, and intestines, 
were sent to a rendering plant that turns animal tissues into soaps and other non-food products.  
However, slaughtering processes can still involve some risk of contamination of the “safe” parts 
of the animal by the infectious tissues.  The meat for human consumption was processed at three 
different plants in Washington and Oregon, and subsequently shipped to wholesalers and retailers 
in Washington, Oregon, California, Idaho, Montana and Nevada
2
.  After the positive test results 
on Dec. 23, 2003, the farm in Mabton was quarantined and efforts were made to trace the 
potentially contaminated meat.  USDA officials subsequently “depopulated” the Mabton herd, 
other Washington and Idaho herds associated with the infected animal, and the herd containing 
the sick Holstein’s calf.  All of the euthanized animals, approximately 500 cattle, tested negative 
for BSE
1
.   
Businesses began pulling potentially infectious beef products from store shelves under a 
voluntary recall starting December 23
rd
.  The total amount of meat recalled, consumed, or thrown 
away by consumers is uncertain, estimates range from 10000 pounds to 38000 pounds
1,2
.  USDA 
officials, fearing a drop in beef sales and exports, were quick to try to reassure consumers of food 
safety.  The discovery of BSE in a Canadian cow earlier in 2003 had resulted in the US, Japan, 
Korea, Australia, and other countries issuing import bans on Canadian cattle, with catastrophic 
effects for the cattle industry in Canada.  The United States Secretary of Agriculture Ann 
Veneman stated she was serving beef to her family for their Christmas dinner, and the town of 
Mabton had a free barbecue a few weeks after the mad cow discovery.
1,3
  Consumers who were 
concerned about food safety could employ extra precautions by buying only whole-muscle cuts 
of beef, rather than ground beef.
3
     
The mad cow discovery caused a great deal of fear among Seattle residents who had 
potentially consumed contaminated beef products, myself included.  One resident, a Jill Crowson, 
even went so far as to file a class-action (group, meaning others can join in) lawsuit against the 
grocery store chain QFC.
2
  QFC had been warned of the meat contamination Dec. 23
rd, yet didn’t 
remove the meat from the shelves until Dec. 24
th
.
2
  The grocery store chain did not try to warn its 
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customers about the recalled beef until Dec. 27
th
, and at that time only with small, easily missed 
signs at the stores.  The QFC stores have a customer rewards program, meaning that shoppers use 
a QFC store card each time they shop, effectively tracing all purchases.  Crowson’s argument was 
that QFC should have used their tracking data to warn consumers.  Jill Crowson had purchased 
ground beef from QFC on Dec. 22
nd
 and Dec. 23
rd
 and had used it to prepare meals for her 
family.2  In January, she contacted QFC and was informed that the beef had indeed been part of 
the batch of meat that was recalled.
2
  This student has not been able to find the results of the 
Crowson versus QFC lawsuit, even after enlisting the help of a friend who is a lawyer.  The 
probable conclusion is that Crowson and QFC reached a settlement before the case went to 
court.
4
  For Crowson and for others who may have consumed infected meat, living with the 
knowledge that they and their families may be bearers of this fatal disease is a heavy emotional 
burden.    
Mad cow disease and the possibility of its transmission to humans has interested me since 
I first heard of it in the 1990s.  I have a personal interest in mad cow disease, as I have close 
family living in the UK and in Seattle.  My parents, sisters and I consumed beef products in 
Seattle at the time of the 2003 mad cow discovery.  The uncertainty of knowing that one may be 
at risk for Creutzfeldt-Jakob disease is something we have to live with, as there is no screening 
test for it at present.  With this paper, I hope to give a concise overview of what we know about 
prion diseases today.     
 
II. Methods 
I have searched PubMed Clinical queries using the Mesh terms/search terms Prion Diseases; 
Creutzfeldt-Jakob syndrome; Fatal Familial Insomnia; Kuru; Gerstmann-Straussler-Scheinker 
Disease; Bovine Spongiform Encephalopathy; Scrapie; Wasting Disease, Chronic; and 
Transmissible Mink Encephalopathy and gone through the systematic reviews listed.  Limits 
imposed on the searches were for English and links to full text.  I have also researched newspaper 
articles and websites for consumers.  A lawyer who is a personal friend has performed searches 
on paid legal research sites for me related to the mad cow case in Seattle.  I have used the 
websites of the Center for Disease Control in the USA, the Veterinary Institute in Norway, and 
United States Department of Agriculture Animal and Plant Health Inspection Service.    
 
III. Human Prion Diseases 
Prion is a combination of two words, infectious and protein.  Prion diseases are inevitably 
fatal.  Human prion diseases include Creutzfeldt-Jakob Disease (CJD), Gerstmann-Straussler-
Scheinker syndrome (GSS), familial fatal insomnia (FFI), and kuru.  CJD has four 
subclassifications, including sporadic (about 90% of all CJD cases occur sporadically), familial, 
iatrogenic, and variant.  Familial CJD, GSS, and FFI are all genetic prion diseases with an 
autosomal dominant pattern of inheritance.  Kuru, iatrogenic CJD, and variant CJD are all 
acquired forms of prion disease.
5,6
 
The prion gene (PRNP) encodes for the prion protein PrP
c
.  In prion disease, PrP
c 
undergoes post-translational modification to the disease-related protein PrP
Sc
.
7
  The precise way 
in which PrP
Sc
 infects the brain is still unclear; it seems to be able to induce a conformational 
change in the normal prion protein PrP
c
.
5
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A. Creutzfeldt-Jakob Disease 
Background 
Creutzfeldt-Jakob Disease (CJD) is a rare, rapidly progressive neurodegenerative disease 
caused by infectious prions.  Prion diseases are inevitably fatal.  H.G. Creutzfeldt is credited with 
the first clinicopathological description of the disease now known as CJD in 1920. In the 
following year another German neurologist, A. Jakob, described four cases of what we now find 
highly suggestive of CJD.  Hence the name Creutzfeldt-Jakob disease.
8
   
Variant CJD was first described in 1996 in the United Kingdom.
9
  It has been undeniably 
linked to the outbreak of mad cow disease, or Bovine Spongiform Encephalopathy.
7
  There are 
various clinical and pathological features which distinguish sporadic CJD from variant CJD.  
Sporadic CJD has occurred throughout the world, whereas variant CJD has occurred mainly in 
the UK and France.
10
 
 
How does vCJD differ from sporadic CJD? 
Sporadic CJD is primarily a disease of older people, with a median age at death of 68 
years.  Variant CJD affects younger people, with a median age at death of 28 years.  Sporadic 
CJD tends to present as dementia, whereas vCJD presents with changes in behavior, psychiatric 
problems, and painful dysesthesias.  Neurological signs appear early in sporadic CJD and later in 
variant CJD.  EEG changes are often present in sporadic CJD, and often absent in variant CJD.  
The pulvinar sign on brain MRI imaging  is present in over 75% of variant CJD cases, and absent 
in sporadic CJD.  In variant CJD (but not in sporadic CJD) deposition of prion amyloid protein is 
found in lymphoid tissues.
9
  
 
Occurrence and Transmission 
CJD is rare, with only 1-2 cases per million people per year
11
 (in Norway about 5 cases 
per year).  Most cases of sporadic CJD occur after age 50.  A cause for sporadic disease has not 
been found but it has been speculated that somatic mutation of the prion protein gene or 
spontaneous change to prion proteins in the brain may be involved.
12
    All cases of familial prion 
disease are caused by germ line mutations in the prion protein gene.
11
  Iatrogenic CJD  is caused 
by the transfer of prions by transplantation, hormones derived from human cadavers,  blood 
transfusion and or contaminated surgical instruments.
13
  
Variant CJD is believed to be transmitted through the consumption of cattle products 
infected with Bovine Spongiform Encephalopathy (BSE).
10
  About 200 people in the world have 
been diagnosed with vCJD after the first ten cases were described in 1996
14
, most of these in the 
United Kingdom.
15
  A sharp decline in the number of new cases has occurred after the year 2000.  
The timing of the vCJD epidemic, which peaked some years after the maximum of the BSE 
outbreak, was consistent with the long incubation period for prion diseases.  It is thought that the 
BSE epidemic was the result of feeding cattle with meat and bone meal contaminated with prions 
from a new type of prion disease that may have originated in sheep or another animal.
16
  The 
practice of using mechanically recovered meat represents a certain risk of contamination of meat 
with brain and spinal cord tissues.
16
   
There is compelling evidence supporting the theory that variant CJD is a human form of 
BSE.  An important piece of evidence rests on the fact that the glycoform pattern of PrP found in 
vCJD is similar to that of BSE (PrP exists in three different glycoforms:  diglycosylated, 
 7 
monoglycosylated and unglycosylated form; the  diglycosylated form dominates in BSE and 
vCJD).
17
  
 
Courtesy of Prof. Jan Mæhlen, UUS   
vCJD has also been transmitted through blood transfusion from infected, asymptomatic 
blood donors.
18
  A study by Hewitt and Will identified three likely cases of transmission of vCJD 
through blood transfusions in the UK.
18 
 Individuals who have lived in the UK for more than one 
year between 1980 and 1996 are permanently banned as blood donors in Norway, as are persons 
who have received blood transfusions in the UK after 1980.
19
  This is due to the risk of 
transmission of vCJD.   
 
Symptoms and signs 
Appleby et al.
13
 found that the most common presenting symptom for all CJD types is a 
cerebellar or gait disturbance.  Dementia, cognitive decline, and memory impairment are also 
common at presentation.  Visual or oculomotor disturbances are frequent, as are changes in 
behaviour and personality.  Myoclonus is also frequently reported as the illness progresses(3).  
Appleby et al. conducted a meta-analysis
13
 to investigate whether the disease presentation varies 
between CJD types and with age.  Variant CJD patients commonly presented with affective 
illnesses and other psychiatric symptoms, whereas sporadic CJD patients most often presented 
with neurological symptoms.  vCJD patients also had more sensory complaints.  Genetic forms of 
CJD tended to present with cerebellar/gait disturbances, dementia/memory impairment/higher 
cerebral dysfunction.  Patients infected with CJD iatrogenically tended to present with delirium 
and confusion.  This may be due to brain damage from dural graft procedures.
13
    
In addition, Appleby et al. found that age can explain differences in the symptom 
presentation of CJD, regardless of the etiology:  “Younger age was associated with a higher 
likelihood of presenting with cerebellar/gait disturbance, visual/oculomotor disturbance, sensory 
disorder, speech disturbance, seizures, vertigo/dizziness, headache, and apraxia…Additionally, 
 8 
younger patients had higher presentation rates of affective illness, sleep disorder, and poor 
concentration”.  Older people are more likely to have other brain disorders (not CJD) and have 
lower cognitive reserves.  This may explain why they were more likely to present with delirium.
13
       
In familial CJD, the age of onset is usually between 30-55 years of age.
20
  The clinical 
picture resembles that of sCJD.    
 
Diagnosis  
Clinicians should be aware of the symptoms of CJD, although it is rare.  Other, more 
common (and treatable) illnesses must be ruled out first, as the diagnosis of CJD will likely be 
devastating for the patient and his family.  Symptoms suggestive of sporadic CJD include rapidly 
progressive dementia, cerebellar disturbances, and problems with vision.  Myoclonus is also 
typical for sporadic CJD.
7 
 
An EEG test will in most sCJD patients show periodic sharp wave complexes.  However, 
these waves can also be present in some other conditions.  The presence of a protein called CSF 
14-3-3 in the spinal fluid also supports the sCJD diagnosis.  An MRI test will help to exclude 
other diagnoses.  A characteristic signal change in the putamen and caudate is suggestive of 
sCJD.
 7,20
   
Inherited/familial CJD can be diagnosed by the family history, if known, and by a blood 
test screening for mutations in PRNP.
7
   
 Iatrogenic CJD is diagnosed by being aware of relevant risk factors, such as having had 
brain surgery, having received pituitary growth hormone or human dura mater grafts, or blood 
transfusions in the UK.  EEG and MRI investigations may be similar to those of patients with 
sporadic CJD.
7
     
For variant CJD, residence in UK during the BSE epidemic is a major risk factor. Some of 
the symtoms of vCJD can be confused with psychiatric disorders.  Key to the diagnosis is the 
observation of ataxia and involuntary movements.  There are important differences which 
distinguish vCJD from sCJD.  The EEG does not show the periodic sharp wave complexes in 
vCJD, and the CSF 14-3-3 test is positive in only about half of the patients.
7
  MRI investigation 
can show a high signal in the posterior thalamus, known as the “pulvinar sign”.9     
Important differential diagnoses include Alzheimer disease, dementia with Lewy bodies, 
and Huntington disease, among others.
20
    
Autopsy is used to confirm the diagnosis of prion disease.  Neuropathological changes in 
the brain include spongiform degeneration, astrocytic gliosis, formation of amyloid plaques and 
loss of neurons.
5,16
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The top picture is a normal brain.  The bottom picture shows the “holes” in the brain, hence the 
name spongiform, and the lack of neurons characteristic of the TSEs.  Pictures courtesy of Prof. 
Jan Mæhlen, Ullevål Universitetssykehus.   
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Treatment  
There is at present no curative treatment for CJD; it is universally fatal.  However, some 
treatments have shown promise in animal experiments.
15
  CJD is caused by the transformation of 
normal prion protein PrP
c 
to PrP
Sc
.  Treatments are based on removing or reducing the amount of 
PrP
c
.  Mice have been genetically manipulated so that they stop producing PrP
c
 after 10 weeks of 
age.  When the gene-manipulated mice were exposed to scrapie, they remained healthy after 52 
weeks, whereas control mice died within 12-18 weeks.
15
  RNA-interference can also be used to 
suppress expression of a gene.  In a study by White et al, scrapie-infected mice were injected with 
a lentivirus with double-stranded RNA directly into the hippocampus.  These mice lived longer 
than controls, and their post-mortem examinations revealed fewer degenerative brain changes.  A 
third possibility for therapy is the use of antibodies, either through passive or active 
immunization.
15
  White et al. found that injecting mice with antibodies against PrP
c
 extended the 
lifespan of scrapie-infected mice from 200 to 500 days.  Theoretically, the binding of the 
antibody to PrP
c
 may prevent its transformation to PrP
Sc
.  A medicine that would work against 
CJD would have to cross the blood-brain barrier or be directly applied into the brain.  Pentosan 
polysulphate has been tested in mice with scrapie and in humans in a small study in the UK.  In 
both the mice and the human studies, it was applied to the ventricles of the brain.  The mice who 
received treatment had a longer incubation time before they showed signs of illness as compared 
to controls.  The human study included only 7 patients, but showed promising results with each 
of the 7 patients attaining a higher survival time than the average for untreated patients.
21
  
Pentosan polysulphate is primarily used to alleviate interstitial cystitis symptoms; its effect on 
CJD is attributed to binding to PrP
c
 and preventing polymerization of PrP
Sc
.
15
    
In a systematic review of treatments for human prion disease published in 2008, Stewart 
and colleagues
12
 found that most studies of therapeutic interventions for prion disease were 
poorly designed or reported, and often included very few patients.  Only one double-blind, 
randomized controlled trial was found, and showed that the drug Flupirtine could help to slow 
cognitive decline, but did not increase survival time.  This systematic review was however 
published before the pentosan polysulphate study mentioned above.  Various types of analgesic, 
anticonvulsant, antidepressant, antifungal, antimalarial, and antiviral drugs have been tested in 
the treatment of prion disease without effect.  Many studies published are case reports of 
individual patients, thus they carry limited statistical weight.
12
 
 
Prevention of iatrogenic prion disease 
 More than 400 patients have contracted CJD iatrogenically.  CJD is proven to transmit 
through contaminated neurosurgical instruments, intracerebral encephalographic electrodes, 
human pituitary hormone, corneal transplant, and dura mater grafts.  vCJD is also transmitted 
through blood transfusion, whereas there is no evidence that sCJD is transmitted via blood 
transfusion.
22
  Prions are notoriously difficult to inactivate, and many sterilization methods are 
ineffective.  Important precautions should be taken when dealing with a high-risk patient in a 
surgical setting.  Instruments should not be allowed to become dry after use, as drying makes 
prions more resistant to inactivation.  Disposable instruments should be used whenever 
possible.
22
  The WHO recommendation for disinfection of surgical instruments is the use of 1 N 
NaOH or 20,000 parts per million active chlorine followed by sterilization.
59 
 Noncritical 
environmental surfaces contaminated with high-risk tissues should be cleaned with detergent and 
then bleach.  Standard disinfection procedures should be used to clean environmental surfaces 
contaminated with low-risk tissues.
58
  There have been theoretical concerns about the risk of 
 11 
prion contamination of dental instruments, but there have not been any proven cases of CJD 
transmission through dental procedures.  When treating patients with known CJD in a dental 
setting, it is recommended that dentists discard instruments (such as endodontic
a
 files) that are 
difficult to clean, and clean heat-resistant instruments according to WHO guidelines for prion 
disinfection.
23
  
 A practical, affordable test for presymptomatic vCJD for blood and organ donors will 
hopefully become available in the future.  However, an article by Duncan et al
24
 discusses 
important ethical considerations in presymptomatic testing.  As the disease is incurable, 
informing asymptomatic blood donors that they are vCJD carriers could be psychologically 
devastating.
24
  This is well enough when it involves blood donation, which is something a person 
volunteers for, and can accept that testing is necessary due to the risk posed to the blood 
recipient, similarly to reasoning for HIV testing with blood donation.  Pre- and post-test 
counselling would be necessary.  However, Duncan argues that it would be beneficial for patients 
to be tested for vCJD before invasive surgeries with a high risk of disease transmission.  This is 
ethically more difficult, as the patient is undergoing the surgery out of necessity for his own 
health, not performing an altruistic act as in blood donation.  The benefit to the operating team of 
knowing the vCJD status must be weighed against the potentially devastating consequences of 
receiving a positive vCJD test for an asymptomatic patient.  In this case, patients could chose to 
not receive the results of a vCJD test.
24
      
 vCJD prevention as related to food safety is discussed below under BSE.   
 
Prognosis 
The prognosis for all types of prion disease is poor, as there is no cure.  The median time 
from the onset of symptoms to death in sporadic CJD patients is 6 months (ranging from 1 month 
to 11 years).
12
  In familial CJD, the mean duration of illness is also around 6 months.
5 
 In vCJD, 
the disease duration is typically 14 months.
5
  In patients infected iatrogenically, the duration of 
disease is similar to that of vCJD.
5
  The ultimate cause of death is usually infection or heart or 
respiratory failure.
25
  
The genetic makeup of patients with vCJD may play a very important role in incubation 
time .
56
  To date, most patients with symptomatic vCJD have been homozygous for methionine at 
codon 129 of the PrP gene.
56
  In a study of kuru patients
56
, Collinge et al. found that people with 
the heterozygous phenotype methionine/valine at codon 129 had incubation times up to 50 years.  
They postulate that “a human BSE epidemic may be multiphasic, and recent estimates of the size 
of the vCJD epidemic based on uniform genetic susceptibility could be substantial 
underestimations”.  This theory seems to be supported by a 2009 case study in the Lancet 
describing a 30-year-old British man who developed vCJD in 2008, and, of great interest, was 
found to be heterozygous for PRNP codon 129.
26
  It is thus possible that there could be a second 
wave of vCJD in the future.  However, a recent large scale British study in which tonsil 
specimens from 63000 individuals who would have been exposed to BSE found a prevalence of 
zero for PrP
Sc 
in tonsillar tissue.
27
  Thus, the risk for healthcare-associated transmission of vCJD 
can be regarded as extremely low.
27 
   
 
                                                 
a
 Related to the pulp of the tooth, which also contains lymphatic tissue 
 12 
B. Genetic prion diseases 
 The genetic prion diseases include familial CJD (fCJD), Gerstmann-Straussler-Schienker 
syndrome (GSS), and familial fatal insomnia (FFI).  These diseases are caused by a mutation of 
the prion protein gene (PRNP) on human chromosome 20.
7
   
1. Familial CJD 
 Approximately 10% of CJD patients have the inherited form of the disease.
15
  The 
symptoms are similar to those of sporadic CJD as described above.  The age of onset is between 
30 and 55 years, although it can also present very late in life.
20
  It is diagnosed based on genetic 
analysis and autopsy findings.  The prognosis is similar to that of sCJD, with a mean disease 
duration period of 6 months.
5
   
2. Gerstmann-Straussler-Scheinker Disease 
 Gerstmann-Straussler-Scheinker disease (GSS) can be caused by various mutations of the 
PRNP gene, most commonly the proline → leucine mutation at codon 102 .20   
Occurrence 
GSS is an extremely rare disease.  It is inherited in an autosomal dominant pattern.
6
    
Symptoms and signs 
 GSS begins around age 50.  It begins with cerebellar ataxia and slowly progresses to 
dementia.
5
  There can also be spasticity, bradykinesia, and increased muscle tone.
20
   
Diagnosis 
 GSS can be diagnosed by genetic analysis and family history.  The presence of multiple 
amyloid plaques in the brain distinguishes GSS from the other prion diseases.
20 
  
Prognosis 
 There is no treatment for GSS.  However, the disease progresses more slowly than the 
other prion diseases, with mean survival of 5-6 years from the time of the onset of symptoms.
5
 
 
3. Familial fatal insomnia 
 
Man with insomnia, photo credit emedicinehealth. 
 Familial fatal insomnia (FFI)  is a genetic prion disease linked to a mis-sense mutation at 
codon 178 of the PRNP gene.
28
  It follows an autosomal dominant pattern of inheritance.
29
  
Aspartic acid is replaced by asparagine at codon 178.
29
  The same mutation can also be found in 
families with fCJD, but the CJD families will have valine expressed at codon 129 of the mutated 
gene, whereas the FFI sufferers have methionine at codon 129 of the mutated gene.
28
  “Non-
familial” FFI also exists in a sporadic form which is clinically similar.28  
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Figure from article by Montagna et al.
28
, showing importance of codon 129 for disease 
phenotype 
 
 
Occurrence and transmission 
 FFI is a rare disease, with about 27 families known to have the disease in the world.  It 
can be transmitted to animals.
28
   
Symptoms and signs 
 FFI typically begins around age 50, although the age of onset ranges from 20-62 years.
29
  
To begin with, the symptoms of the disease can be confused with stress or fatigue, as patients 
complain of difficulty sleeping.  They may be very drowsy in the daytime.  Double vision, 
diplopia, is common.  Patients often experience hallucinations and appear to be in a dream-like 
state that can be confused with psychosis.  Symptoms of sympathetic overactivation, such as 
tachycardia, hypertension, perspiration, and pyrexia occur.
29
  Later, patients develop gait 
disturbances, myoclonus, dysarthria, dysphagia, and sphincter incontinence.
29
  Interestingly, 
general intelligence is preserved in FFI, although patients do become progressively more 
confused.
28
  At the end of life, they spend more and more time in a dream-like state.
28,29
 
Diagnosis 
 The disease is diagnosed on the basis of genetic analysis and family history.  Sleep 
histograms show loss of deep-sleep and loss of slow-wave EEG activity.  Another key finding is 
that body temperature, blood pressure, and heart rate are higher at rest than while awake.
28  
Circadian rhythms are severly disrupted, including the secretions of various hormones important 
in regulating autonomic functioning.
28
 
Treatment 
 The only treatment for FFI today is merely palliative.  Scientists have examined the use of 
various drugs to induce sleep, including benzodiazepines, sedatives, and GHB.
29
  None of these 
has provided patients with a cure.   
Prognosis 
 14 
 Patients typically live a mean of 18.4 months from the onset of insomnia until the time of 
death.  FFI patients’ children will have a 50% chance of inheriting the disease.  Patients with the 
Met-Met genotype have a shorter survival time than patients with the Met-Val genotype.
28
  
 
C. Kuru 
Background 
Kuru is a prion disease caused by endocannibalism practices in Papua New Guinea.  It has 
only been found among the Fore people and their close neighbors in Papua New Guinea .
60
  Kuru 
was considered an epidemic, with more than 2700 cases from 1957-2004.
56
.  Women were more 
exposed than men, resulting in the “motherless nuclear family” becoming common among the 
Fore people.
30
  Deaths among young women were so many that it became common practice to 
withhold the “bride price” until the bride had lived long enough to produce a child.30  The Fore 
people believed the disease was caused by sorcerers.
30
   
Occurrence and transmission 
 Anthropologists Robert and Shirley Glasse were the first to suggest that cannibalism 
might be the route of transmission of the disease .
30
  The Fore people likely began the practice of 
ritual consumption of dead relatives sometime in the late 19
th
 or early 20
th
 century.  According to 
the oral history of the Fore people, people first started dying of kuru sometime between the 1920s 
and 1940s.  All body parts except the gallbladder were consumed, and victims of kuru were 
considered favourable for consumption.
30
  Adult women and small children of both sexes 
participated in the feasts, while boys over the age of approximately 6-8 years and adult men did 
not participate.
56
  After the practice of cannibalism was banned by the Australian government in 
the late 1950s, the incidence of disease in young children dropped.
60 
Gajdusek and colleagues 
proved that kuru was a transmissible disease when they succeeded in inoculating the chimpanzee 
Georgette with brain material from a human patient.
31
   
 The incubation period of kuru has a huge range, from 5 to possibly more than 50 years.
56
  
There have been no cases of Kuru in patients born after 1959.
 56
    
Symptoms 
 Kuru often begins with a prodromal phase of headaches and pain.
60
  This is followed by 
cerebellar ataxia, which progresses until the person is immobilized.
60
  The cognitive processes 
can be fairly well-preserved.
56
  Chronic emotional instability is common
32
, kuru has also been 
called “the laughing sickness”.33  There are three stages in the progression of the disease: the 
ambulant, sedentary, and terminal stages.
60
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The boy on the left, sick with kuru, is unable to stand without assistance.  Courtesy of Prof. Jan 
Mæhlen, UUS. 
Diagnosis 
 Kuru is a very distinctive disease and was usually easily recognized by the patients and 
their families.
56
  Monitoring of the disease is performed by the Papua New Guinea Institute of 
Medical Research.
56
  Histopathological changes on autopsy are most noticeable in the 
cerebellum, but are also found to a great extent in other parts of the brain and spinal cord.
60
  
Spongiform change, neuronal loss, and gliosis are typical.
32
   
Prognosis 
 Patients live an average of 12 months from the onset of symptoms until the time of 
death.
60
  Collinge et al. have suggested that heterozygosity (Methionine-Valine) for the PRNP 
129 genotype gives less susceptibility to kuru and a longer incubation time, ranging from 34-56 
years, in those infected.
56
  The ban (and enforcement of it) on cannibalism from the mid-1950s 
has given a unique opportunity to study the incubation period, as one to two people continued to 
develop kuru each year up until 2004.
56
  Hopefully, the disease has now been eradicated and will 
merely remain a fascinating part of medical history.   
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IV. Animal prion diseases  
 
Healthy cattle, picture from Annual Reports 2008 of Veterinærinstituttet 
 
 
Downer cow, unable to stand, from Wikipedia. 
A. BSE 
Bovine spongiform encephalopathy (BSE) is a TSE which affects cattle.
34
  BSE causes 
various clinical signs including changes in mental status, posture, and movement, and reduced 
milk yield.
57
  Examination of the brain in sick cattle shows vacuolization and scrapie associated 
fibrils.
57
   
The first BSE case was observed in 1985 in the UK (Ducrot).
57
  There have been over 
180,000 cases of BSE in the UK, as well as a number of cases in the rest of Europe, Japan, Israel, 
Canada, and the USA.
34
  The use of meat and bone meal (MBM) in cattle feed has been strongly 
implicated in the outbreak of the BSE epidemic.  Changes in the early 1980s in the way MBM 
was produced are thought to have allowed the sheep scrapie prion protein to survive the cooking 
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process.
16
  The use of ruminant
b
 MBM for ruminant feed was forbidden in 1988 in the UK, and 
the use of specified risk materials/specified bovine offals
c
 was banned in 1990.
57
  The use of 
MBM was forbidden in Norway in 1990.
34
   The use of MBM in the production of feed for 
ruminants has been forbidden in the EU since 1994, and laws requiring the use of high 
temperature and pressure when producing MBM were passed.
34
  EU regulations to prevent TSEs 
now include:  surveillance of TSEs in animals, particularly cattle, sheep, and goats; removal and 
destruction of organs that are particularly infectious (specified risk materials); better slaughtering 
techniques in cattle to avoid contamination with brain matter; limited use of MBM; and 
regulations on import and export of animals or products that could be infectious.
34
  The United 
States passed laws in 1997 and 2008, first prohibiting the use of mammalian protein in feed for 
ruminant animals, and subsequently prohibiting the use of brain and spinal cord tissues from 
cattle over 30 months of age in animal feed.
35
  
In Norway, a passive surveillance program for BSE was in place from 1990 through 2000, 
and active surveillance from 2000 onwards.  Starting in 2001, an ELISA test to detct PrP
Sc
 was 
made available.
36
  In the Norwegian program, clinically suspicious cattle, downer cattle over age 
24 months, emergency slaughtered cattle over age 24 months, cattle over 24 months with 
abnormal ante-mortem findings, slaughtered cattle with unknown age or origin, and slaughtered 
imported cattle from any country are tested.  In addition, 10,000 randomly selected healthy 
slaughtered cattle over age 30 months are examined yearly for BSE.
36 
 Norway is compliant with 
all EU/EEA regulations and in addition has some regulations that are even more stringent.
34
  It is 
reasonable to conclude that there is negligible risk involved in the consumption of beef in 
Norway.   
 Although there are some vocal dissidents, it is now generally agreed that BSE is 
transmitted to people through the oral route and causes variant CJD.  In a 1996 Lancet article, 
Will et al. described 10 new cases of a new variant of CJD, all affecting younger people.
14
  They 
suggested that these patients, whose illnesses began earliest in 1994, had become ill due to the 
consumption of contaminated beef.  This was consistent with an incubation period of 5-10 years, 
with the mid-late 1980s likely being the peak of the BSE exposure to the UK population.  SBO 
were excluded in human food after November 1989, so the exposure probably was much less 
after this point.  The British government had maintained that beef was safe to eat, despite the 
BSE outbreak. In a memorable moment in 1990, Agriculture Minister John Gummer was 
photographed together with his daughter eating hamburgers in an attempt to reassure the public 
of the safety of British beef.
37
  These reassurances now rang false and consumers panicked.   
 
                                                 
b
 Ruminant:  An animal that chews the cud 
c
 Specified bovine offals:  the term used in the UK to denote tissues that can be infected with the agent of bovine 
spongiform encephalopathy (BSE), namely brain and spinal cord, spinal ganglia, retina, and terminal small intestine 
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John Gummer and 4 year-old Cordelia.  BBC news. 
The BSE epidemic and ensuing vCJD scare had a drastic impact on the British cattle 
industry.  At the peak of the epidemic, in 1992, approximately 1% of British cattle were infected 
with BSE.  However, it was not until 1996, when scientists discovered the link between vCJD 
and BSE, that the industry really suffered.  Cattle prices fell by 25%, consumer consumption of 
beef fell 26%, and the export market for beef was virtually eliminated.
38
    The EU banned 
internal trading in UK beef, and the ban was not lifted until 1999.  In the year following the 
outbreak of the BSE/vCJD epidemic, the total estimated economic losses due to BSE in the UK 
were estimated to be $980 million.
39
  
Is it safe to eat beef?  Countries have varying levels of surveillance for BSE and varying 
regulations regarding which tissues are deemed SRM.  Importantly, many countries have never 
even had documented cases of BSE.  There is no test to identify SRM on a beef carcass.
40
 Even 
with the removal of specified risk materials, conventional slaughtering practices can still 
potentially allow contamination of meat with brain material.  The use of captive bolt stunners, 
which damage the brain while the cow’s heart is still beating, can potentially allow infectious 
brain material to enter the blood.  Pneumatic captive bolt stunning, in which air is injected into 
the brain, has been banned in the U.S. and many other countries.
40
  Other risky practices include 
the insertion of a rod through the stunner to destroy the brain stem and spinal cord, which 
prevents leg kicking and benefits the safety of abattoir workers
d
.  In Norway, the use of captive 
bolt stunners has been modified, so that the bolt does not penetrate to the brain.  The safest 
methods of stunning appear to be either penetrative captive bolt stunning without pithing or 
nonpenetrative captive bolt stunning.
40
.  The floor, equipment, and abattoir
e
 personnel can also 
potentially be contaminated with CNS tissue; it is particularly of concern that workers could 
carry CNS tissue with them outside of the facilities and contaminate other areas
40
.  Other 
problematic areas in conventional cattle slaughter are the removal of the head, typically done 
with a knife, and the splitting of the carcass along the spine
41
.  Carcass splitting represents a risk 
both for dissemination of CNS tissues to the carcass and for contamination of the saw and 
subsequent carcasses.  Bowling et al. have performed multiple studies showing that washing done 
on the saw in between carcasses is often not sufficient to remove all CNS tissue
40
.  Alternative 
methods for removing meat products from the carcass without splitting have been researched, but 
the benefits must be weighed against additional costs and inconvenience.         
  
B.  Scrapie 
 Scrapie was the first TSE known to man.  Some authors claim scrapie reports have dated 
as early as the 15
th
 century.  The first description of scrapie may have been as early as 1732, but 
this publication is not found.  However, a 1772 publication refers to scrapie being reported over 
the last 40 years, which would be consistent with the first paper in 1732.  One of the first texts on 
scrapie, written in the year 1750, translated from German, describes the symptoms as follows:  
“…scrapie, an illness recognizable in the recumbency of the animal.  It nibbles at its claws and 
feet and scratches its back against posts.  It ceases to prosper, looses appetite and finally gets 
weary.  They drag themselves for a long time, are consumed more and more, and in the end, they 
are doomed to death”.  This early description of the symptoms remains accurate today.42 Other 
symptoms of scrapie are apprehensiveness or uneasiness during handling or feeding, tremors of 
                                                 
d
 This practice is known as “pithing”. 
e
 slaughterhouse 
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the head or neck, and isolation from the flock.
43
  In the past, scrapie has been known by various 
descriptive names:  cuddie trot, la maladie trotteurs, prurigo lumbar, rickets, rubbing disease, 
scratchie, shakings, shrugginess, tempermanner, and trotting disease.
42 
 The incubation time is 
from 2-5 years, and the survival time after the onset of symptoms is from 1-6 months.
43
 
Even in olden times, farmers had an understanding that scrapie was infectious, and in the 
19
th
 century it was commonly believed that scrapie was spread by sexual intercourse.
42
  Others 
believed scrapie was a spontaneous disease, and some believed it to be a hereditary disease, since 
lambs of infected ewes often contracted the disease.
42 
 Cuille and Chelle demonstrated in 1936 
that scrapie could be transmitted to sheep and goats via inoculation with brain and spinal cord 
material.  In another interesting experiment in the 1930s, J.R. Greig showed that a healthy flock 
of sheep could be infected with scrapie by grazing in the same field that a sick flock of sheep had 
grazed on.
42
  We now know that prions can effectively bind to soil and remain infectious for 
years.
44
  One study showed that a scrapie-infected sheephouse and pasture remained infectious 
for 16 years, despite having been decontaminated.  Scrapie prions are shed in urine, feces, saliva, 
blood, and birthing matter.  There is at present no effective and practical method for detecting or 
measuring the presence of prions in the environment.  Disposal of infected carcasses may be an 
environmental problem; in the BSE outbreak in the UK 6000 cattle carcasses were put in 
landfills, possibly posing a risk of infection.
44
  The most effective method of disposal of prion-
contaminated material is incineration at 1000 degrees Celsius, however, this is not always 
practically possible, as it is inconvenient to incinerate large amounts of contaminated soil, 
vegetation, fences, paddocks, etc.
44 
  
 An unusual type of scrapie was discovered in Norwegian sheep in 1998.  The genotypes 
of the affected sheep are consistent with resistance to the classical form of scrapie.  The 
distinguishing clinical feature of the Nor98 scrapie is ataxia.
45
  The sheep also experience anxiety 
and loss of body condition.  They do not generally seem to experience the pruritus associated 
with classical scrapie.  The brains also have a different appearance and distribution of the PrP
Sc
  
protein than in classical scrapie.  In classical scrapie, the dorsal motor nucleus of the vagus is the 
most affected structure.  This structure is not affected in Nor98 scrapie.  Sheep with Nor98 
scrapie tend to be older.  It is possible that atypical/Nor98 scrapie is a sporadic, non-infectious 
disease, similar to sporadic CJD.  It often occurs as single cases within a flock, whereas classical 
scrapie tends to affect multiple sheep within a flock.
45
   
Classical crapie is found all over the world with the exception of Australia and New 
Zealand.  Goats can also become infected.  Nor98 scrapie has been found in most countries in 
western Europe.
46
  The Norwegian surveillance program for scrapie includes examination of all 
animals with clinical signs of scrapie, examination of slaughtered fallen stock over 18 months, 
examination of randomly selected slaughtered healthy sheep over 18 months, and examination of 
goats which have died or been killed on the farm
47
. Today, as in the past, the only remedy for 
farmers with scrapie-infected sheep is to cull all affected animals.
42
  Genetic selection for scrapie-
resistant sheep has also been explored as an alternative.   
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C. Chronic Wasting Disease 
 
Emaciated animal with CWD, photo credit Dr. Elizabeth Williams, University of Wyoming 
 Chronic wasting disease (CWD) is a TSE affecting mule deer, white-tailed deer, Rocky 
Mountain elk, and Shira’s moose.  It is found in North America and South Korea.  CWD is 
notably different from BSE and scrapie in that it occurs in free-ranging animals as well as in 
domestic herds.  Pathologists Williams and Young were the first to describe CWD in captive 
mule deer in a 1980 publication
48
.  It is thought that CWD originated in mule deer and 
subsequently spread to elk and white-tailed deer.
55
  While moose can be infected with CWD, they 
tend to live solitary lives, not in herds, which may protect them somewhat from infection.
48
    
 
Historic distribution of CWD from 1977-2004.  Dark gray areas for CWD in farmed cervids, red 
for CWD in free-ranging cervids.  From article by CJ Sigurdson.
48
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CWD is likely horizontally transmitted among cervid
f
 animals.  CWD can be spread 
through direct contact among animals, but the mechanism is unknown.
55
  Prions can bind to soil 
particles and remain infectious for long periods of time.
55
  Environmental contamination is thus a 
risk for CWD.  Prion infectivity in CWD is found in the CNS, pancreas, adrenal gland, blood, 
and skeletal muscle.
48
  Sheep and cattle grazing on areas shared with CWD-infected cervids may 
be exposed to CWD through the oral route, but there appears to be a strong species barrier.  Even 
when cattle are exposed to CWD by intracerebral inoculation, less than half develop the disease.  
Hunters and others who consume venison may also be exposed to CWD, but there has been no 
epidemic of human TSE infection in the geographic areas endemic for CWD.
48
  State authorities 
advise hunters to avoid harvesting cervids that appear ill and to take precautions when processing 
the meat.
55
 
 How can farmers, hunters, gamekeepers and veterinarians recognize CWD?  E.S. 
Williams described the manifestations of CWD in detail, noting that animals infected with CWD 
can exhibit symptoms resembling many other diseases, including hemorrhagic disease, meningeal 
worm infection, and locoweed intoxication.
55 
 Progressive CWD disease causes weight loss and 
behavioral changes, such as isolation from the herd, over weeks or months.  Animals may 
salivate excessively due to difficulty in swallowing.  They may also exhibit head tremors, ataxia, 
and an altered stance.
55
  Changes in weight and body condition can be misinterpreted as illness, 
when they in fact represent seasonal variation in the animal’s body mass.  From the time of onset 
of clinical disease, death usually occurs within 4 months.  Free-ranging cervids are more likely to 
have a shorter survival time than captive cervids, due to a reduced ability to find food and water 
and reduced capacity to avoid predators and vehicles.
55
 
 Diagnosis of CWD is done by immunohistochemistry, which is considered to be the gold 
standard.  Samples are taken from the animal’s retropharyngeal lymph nodes or obex and are 
analyzed at U.S.D.A. approved laboratories.
48
  Histopathological examination of brains of 
animals with CWD reveals bilateral, symmetrical spongiform degeneration and amyloid 
plaques.
55
  
What is being done about CWD?  CWD affects farmed and wild cervids and has a 
negative economic impact on the hunting industry and on sales of farmed cervids and cervid 
products.
49
  State and provincial agencies in the U.S. and Canada are working to identify sick 
animals, quarantine and depopulate herds with sick animals, and to provide compensation to 
affected farmers.  There are also programs in place to certify healthy herds, in which there has 
been no CWD after 5 years of monitoring.  Monitoring CWD in wild cervids is a greater 
challenge.  Efforts include surveillance, guidelines for hunters, and reduction of the cervid 
population.
55 
 It is unlikely that complete eradication of CWD in free-ranging cervids will be 
possible, but hopefully control within domestic herds can be achieved.     
 
 
D. Transmissible Mink Encephalopathy 
 Transmissible mink encephalopathy (TME) is a rare TSE affecting ranched mink.  The 
first cases were reported in 1947 on a Wisconsin farm.  The disease has since been documented 
in other U.S. states, Canada, East Germany, Finland, and the former Soviet Union.
50
 The last 
outbreak was in Wisconsin in 1985.
51
   
                                                 
f
 Hoofed mammals of the family Cervidae 
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 TME is thought to be acquired orally when mink eat feed contaminated with prions, 
possibly from a rare strain of BSE prion called L-type.  In the first outbreak of TME in the U.S., 
all the affected farms had been using feed from the same producer, which strongly points to an 
oral route of transmission.
51
  Wisconsin, where most of the U.S. TME cases have been, is a dairy 
state, and aged cattle are frequently used in mink feed.
51
  In one case, a rancher made his own 
feed, composed of commercial feed and meat from sick or downer cattle.
51
  TME can also be 
experimentally transmitted from mink to cattle.
51
  When it occurs, TME tends to affect most or 
all adult animals within a ranch, but kits
g
 seem to be spared, even when they are nursing from 
infected dams
h
.
50
 Mink-to-mink transmission is possible, but unlikely, as there is usually only one 
mink per cage and the minks have no direct contact with each other.
50
 The incubation period of 
TME is 7-12 months.
52
  
 The symptoms of TME include changes in normal grooming behavior, soiling of the nest, 
difficulty swallowing and feeding, and arching of the tail over the back.  Eventually, affected 
minks become uncoordinated, with jerky motions.  The minks ultimately become somnolent and 
unresponsive before death occurs.  Survival time from the onset of symptoms is only 2-6 
weeks.
51,52
  Histopathological examination reveals spongiform change, astrocytic gliosis, and 
amyloid plaques.
51
  Western blotting or immunohistochemistry can detect accumulation of prions 
in the CNS.
50
  
 
Sick mink with TME, photo credit PP Liberski 
 
Spongiform change in TME, photo credit PP Liberski 
                                                 
g
 Baby mink 
h
 Females 
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 Ranch owners are now aware of the danger of feeding infected meat from sheep or cattle 
to minks, and the last outbreak of TME in the U.S. was in 1985.
52
  Hopefully, there will be no 
further TME infections in the future other than those induced in scientific laboratories.   
E.  BSE related diseases  
 The BSE-related diseases include feline spongiform encephalopathy of zoological and 
domestic cats (FSE) and TSE in zoological ruminants and non-human primates.
52
  Feline 
spongiform encephalopathy was first reported in the U.K. in 1990.
53
  Similar cases in domestic 
cats were reported in Northern Ireland, Norway, and Liechtenstein.  The infected cats, all of 
whom were over 2 years of age, exhibited changes in behaviour, ataxia, hypermetria, and tactile 
and auditory hyperesthesia.
52
  The number of new infections dropped significantly following the 
U.K. ban on the use of specified bovine offals in 1990, and there has only been one FSE case in a 
cat born after the BSO ban.  All of the non-domestic cats with FSE lived in zoos in Great 
Britain
52
; it is assumed that the consumption of BSE-infected cattle carcasses was the mode of 
transmission.  The geographical pattern of FSE, with nearly all of the cases located in Great 
Britain, as well as the rapid decline in new infections following the SBO ban, strongly points to a 
close association with the BSE epidemic.  Mice inoculated with brain material from FSE-infected 
cats have the same incubation period and histological appearance as mice inoculated with BSE
54
.  
 A variety of other exotic zoo animals residing in the U.K., all in the family Bovidae
i
, were 
also infected with TSE.  Most of the animals had been fed meat and bone meal.
53
  A spongiform 
encephalopathy has also been described in non-human primates in France in the 1990s; it is likely 
that these animals consumed feed contaminated by infected British beef
52
.            
V. Discussion 
 Prion diseases are progressive, fatal, neurodegenerative diseases caused by the 
accumulation of misfolded prion proteins in the brain.
6
  Prion disease affects animals and people, 
and can be transmitted between species.
5
  They can occur both in wild and in domesticated 
animals.
52
  Infection can result from the consumption of contaminated feed, from cannibalism, 
from exposure to prions in soil, or from medical procedures.
7,42,55,56,57
  Some forms of prion 
disease are genetic, and follow an autosomal dominant pattern.
20
  Genetics play an important role 
in prion disease, with certain genotypes being more resistant to infection and having longer 
incubation times if infection does occur.
56
  The symptoms and presentation of prion disease vary 
greatly; prion diseases can present as dementia, psychosis, sleep disturbances, or behavioural 
changes.
13
  The incubation times are generally long, but the duration of illness, once it is 
apparent, is short.  Sadly, the treatments available for human prion diseases today can only be 
described as experimental or palliative at best.
15
  Even in case histories presented as “success 
stories”, patients usually have achieved just a few months more survival time than expected 
without treatment.
12
  Finding a treatment for prion diseases is a great challenge.  Since prion 
diseases are very rare, there are practical difficulties in recruiting enough patients to conduct a 
statistically sound study.  Diagnosis can also be difficult, and some patients may not receive an 
accurate diagnosis until the time of autopsy.
7
  Additionally, although we know that the aberrant 
prion protein causes disease, we still do not even understand the function of the normal prion 
protein PrP
c
.
5
 
                                                 
i
 Bovidae:  cloven-hoofed mammals, including, but not limited to, bison, oryx, nyala, kudu, and eland. 
 24 
 Prevention of iatrogenic CJD is a medical issue of great importance.  The risk of 
contracting CJD from a medical or dental procedure is extremely low, especially in countries 
with a low prevalence of vCJD, but the consequences of iatrogenic transmission are devastating 
for the unfortunate patients affected.
24
  The risk can be reduced by using disposable instruments 
and proper cleaning of re-usable instruments.
58
  Although it would be ideal to disinfect all 
surgical instruments so that one would be certain that all prions are removed, this is time-
consuming and would cause significant wear on the instruments.
59
  It is conceivable that doctors 
may test patients who are undergoing brain surgery in the future for CJD, once such a test 
becomes available.
24
      
 Scientists and government officials have succeeded in eradicating some prion diseases, 
notably kuru
60
 (which was caused by cannibalism) and transmissible mink encephalopathy
51
.  
The BSE epidemic remained largely contained to Great Britain due to strict sanctions placed on 
export of British cattle products and restrictions on the use of specified risk materials in food for 
animals and people.
57
  More stringent regulations for slaughtering of cattle also have reduced the 
risk of contamination of meat with brain tissue, but this risk cannot be regarded as completely 
eliminated.
40
  Researchers continue to investigate alternative, less risky, methods of slaughtering 
cattle but, especially for countries with a low prevalence of BSE, the benefits may not justify 
higher costs and time expenditure.  BSE is particularly worrisome as it is shown to transmit to 
humans
14
, yet other animal prion diseases, such as scrapie and CWD, have not been shown to 
transmit to humans, despite both oral exposure and exposure to blood during slaughtering.
61,55
 
 For animals infected with TSEs, the only “treatment” available in the foreseeable future 
will continue to be slaughter.  The economic effects of TSEs in animals can be disastrous, as we 
saw during the BSE epidemic in Britain.
38
  The threat of economic ruin will hopefully keep 
governments, farmers, and slaughterhouses motivated to strictly follow and improve guidelines 
for acceptable animal feed products and slaughtering methods.  
 Many mysteries remain in the rare but fascinating world of prion diseases.  Even diseases 
we might think we know well, such as scrapie, continue to surprise and present themselves in 
new forms, as in the recent outbreak of Scrapie Nor98.
45
  Genetics play an important role in prion 
diseases, and gene therapy may eventually be a focal point of treatment.
15
  In the coming years, it 
will be particularly interesting to see whether or not there will be a second wave of vCJD 
infection in the UK among patients who are heterozygous for PRNP codon 129.  Researchers will 
aim to develop methods of effective prion disease detection in humans
24 
and search for effective 
treatments.  The function of the healthy prion protein, the nature of the infectious agent PrP
Sc
, the 
manner in which peripherally administered prions travel to and invade the brain, and the 
mechanism behind the resulting spongiform degeneration are all topics which are not fully 
understood and will undoubtedly be the subject of further studies.
62
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